Published in Nephrol Dial Transplant on November 11, 2006
Comparison of markers of oxidative stress, inflammation and arterial stiffness between incident hemodialysis and peritoneal dialysis patients--an observational study. BMC Nephrol (2009) 0.76
Influence of Malondialdehyde and Matrix Metalloproteinase-9 on Progression of Carotid Atherosclerosis in Chronic Renal Disease with Cardiometabolic Syndrome. Mediators Inflamm (2015) 0.75
The effect of dialysis modality (PD and HD) on cardiac morphology and functions in chronic kidney disease patients at very high cardiovascular risk. Nephrol Dial Transplant (2007) 0.75
Successful initiation and maintenance of hemodialysis in an adult patient with complete transposition of the great arteries. Clin Exp Nephrol (2010) 0.75
Cardiovascular disease in haemodialysis and peritoneal dialysis: arguments pro peritoneal dialysis. Nephrol Dial Transplant (2006) 2.17
Effect of treatment of hyperuricemia with allopurinol on blood pressure, creatinine clearence, and proteinuria in patients with normal renal functions. Int Urol Nephrol (2007) 3.06
Biosimilars and biopharmaceuticals: what the nephrologists need to know--a position paper by the ERA-EDTA Council. Nephrol Dial Transplant (2008) 2.42
Anaemia management in patients with chronic kidney disease: a position statement by the Anaemia Working Group of European Renal Best Practice (ERBP). Nephrol Dial Transplant (2008) 2.24
Electrocardiographic P-wave characteristics in patients with end-stage renal disease: P-index and interatrial block. Int Urol Nephrol (2012) 2.12
A European Renal Best Practice (ERBP) position statement on the Kidney Disease Improving Global Outcomes (KDIGO) clinical practice guidelines on acute kidney injury: part 1: definitions, conservative management and contrast-induced nephropathy. Nephrol Dial Transplant (2012) 1.94
Educating end-stage renal disease patients on dialysis modality selection: clinical advice from the European Renal Best Practice (ERBP) Advisory Board. Nephrol Dial Transplant (2010) 1.90
Global differences in dialysis modality mix: the role of patient characteristics, macroeconomics and renal service indicators. Nephrol Dial Transplant (2013) 1.88
Vascular calcification: a stiff challenge for the nephrologist: does preventing bone disease cause arterial disease? Kidney Int (2004) 1.72
Fibroblast growth factor 23 and fetuin A are independent predictors for the coronary artery disease extent in mild chronic kidney disease. Clin J Am Soc Nephrol (2010) 1.65
Microvascular disease and its role in the brain and cardiovascular system: a potential role for uric acid as a cardiorenal toxin. Nephrol Dial Transplant (2010) 1.65
Predicting mortality in haemodialysis patients: a comparison between lung ultrasonography, bioimpedance data and echocardiography parameters. Nephrol Dial Transplant (2013) 1.62
Serum sclerostin and adverse outcomes in nondialyzed chronic kidney disease patients. J Clin Endocrinol Metab (2014) 1.57
Is it time for spironolactone therapy in dialysis patients? Nephrol Dial Transplant (2006) 1.53
Global variation in renal replacement therapy for end-stage renal disease. Nephrol Dial Transplant (2011) 1.50
Negative outcome studies in end-stage renal disease: how dark are the storm clouds? Nephrol Dial Transplant (2007) 1.44
A randomized study of allopurinol on endothelial function and estimated glomular filtration rate in asymptomatic hyperuricemic subjects with normal renal function. Clin J Am Soc Nephrol (2011) 1.40
The protein science of biosimilars. Nephrol Dial Transplant (2006) 1.36
Use of phosphate-binding agents is associated with a lower risk of mortality. Kidney Int (2013) 1.35
Target haemoglobin to aim for with erythropoiesis-stimulating agents: a position statement by ERBP following publication of the Trial to reduce cardiovascular events with Aranesp therapy (TREAT) study. Nephrol Dial Transplant (2010) 1.34
Kidney Disease: Improving Global Outcomes guidelines on anaemia management in chronic kidney disease: a European Renal Best Practice position statement. Nephrol Dial Transplant (2013) 1.28
Magnesium supplementation helps to improve carotid intima media thickness in patients on hemodialysis. Int Urol Nephrol (2008) 1.27
Pulmonary hypertension in CKD. Am J Kidney Dis (2012) 1.19
Phosphate - the silent stealthy cardiorenal culprit in all stages of chronic kidney disease: a systematic review. Blood Purif (2009) 1.19
Endorsement of the Kidney Disease Improving Global Outcomes (KDIGO) Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Guidelines: a European Renal Best Practice (ERBP) commentary statement. Nephrol Dial Transplant (2010) 1.11
Factors affecting the quality of life of haemodialysis patients from Romania: a multicentric study. Nephrol Dial Transplant (2008) 1.11
Erythropoiesis stimulatory agent- resistant anemia in dialysis patients: review of causes and management. Blood Purif (2009) 1.10
Relationship between serum magnesium levels and cardiovascular events in chronic kidney disease patients. Am J Nephrol (2012) 1.09
Randomized clinical trial of the iron-based phosphate binder PA21 in hemodialysis patients. Clin J Am Soc Nephrol (2012) 1.09
Causes and consequences of increased arterial stiffness in chronic kidney disease patients. Kidney Blood Press Res (2007) 1.06
Lipid, blood pressure and kidney update 2013. Int Urol Nephrol (2014) 1.05
Optimal composition of the dialysate, with emphasis on its influence on blood pressure. Nephrol Dial Transplant (2004) 1.05
Posttransplantation anemia in adult renal allograft recipients: prevalence and predictors. Transplantation (2006) 1.03
Monocyte subpopulations and cardiovascular risk in chronic kidney disease. Nat Rev Nephrol (2012) 1.02
Coronary artery calcification and aortic pulse wave velocity in chronic kidney disease patients. Kidney Int (2004) 1.01
Randomized trial of bioelectrical impedance analysis versus clinical criteria for guiding ultrafiltration in hemodialysis patients: effects on blood pressure, hydration status, and arterial stiffness. Int Urol Nephrol (2011) 1.01
Clinical usefulness of novel prognostic biomarkers in patients on hemodialysis. Nat Rev Nephrol (2011) 1.01
Cinacalcet in patients with chronic kidney disease: a cumulative meta-analysis of randomized controlled trials. PLoS Med (2013) 1.01
Anemia after renal transplantation. Am J Kidney Dis (2006) 1.01
Evaluation of peritoneal membrane characteristics: clinical advice for prescription management by the ERBP working group. Nephrol Dial Transplant (2010) 0.99
Serum vitamin D levels are independently associated with severity of coronary artery disease. J Investig Med (2012) 0.97
Methods and potential biomarkers for the evaluation of endothelial dysfunction in chronic kidney disease: a critical approach. J Am Soc Hypertens (2010) 0.96
Magnesium in chronic kidney disease: challenges and opportunities. Blood Purif (2010) 0.96
Elevated serum uric acid predicts angiographic impaired reperfusion and 1-year mortality in ST-segment elevation myocardial infarction patients undergoing percutaneous coronary intervention. J Investig Med (2011) 0.95
Pregabalin versus gabapentin in the treatment of neuropathic pruritus in maintenance haemodialysis patients: a prospective, crossover study. Nephrology (Carlton) (2012) 0.95
Current management of secondary hyperparathyroidism: a multicenter observational study (COSMOS). J Nephrol (2008) 0.95
Arrhythmias in hemodialysis patients. J Nephrol (2009) 0.94
Assessment of arterial stiffness for clinical and epidemiological studies: methodological considerations for validation and entry into the European Renal and Cardiovascular Medicine registry. Nephrol Dial Transplant (2013) 0.93
COSMOS: the dialysis scenario of CKD-MBD in Europe. Nephrol Dial Transplant (2012) 0.92
Diagnosis of tuberculosis in dialysis patients: current strategy. Clin J Am Soc Nephrol (2010) 0.92
Sirolimus--challenging current perspectives. Ther Drug Monit (2006) 0.92
Serum uric acid level and endothelial dysfunction in patients with nondiabetic chronic kidney disease. Am J Nephrol (2011) 0.92
Sleep disorders: a systematic review of an emerging major clinical issue in renal patients. Int Urol Nephrol (2007) 0.92
Arterial stiffness in dialysis patients: where are we now? Int Urol Nephrol (2009) 0.92
The prevalence of chronic kidney disease in the general population in Romania: a study on 60,000 persons. Int Urol Nephrol (2011) 0.91
Causes and mechanisms of nondipping hypertension. Clin Exp Hypertens (2008) 0.90
Uric acid in hypertension and renal disease: the chicken or the egg? Blood Purif (2010) 0.90
Influence of body mass index on the association of weight changes with mortality in hemodialysis patients. Clin J Am Soc Nephrol (2013) 0.89
Nutritional status evaluation and survival in haemodialysis patients in one centre from Romania. Nephrol Dial Transplant (2009) 0.89
The relationship between chronic volume overload and elevated blood pressure in hemodialysis patients: use of bioimpedance provides a different perspective from echocardiography and biomarker methodologies. Int Urol Nephrol (2010) 0.89
Sodium bicarbonate for the prevention of contrast-induced nephropathy: a meta-analysis of 17 randomized trials. Int Urol Nephrol (2009) 0.88
Balkan endemic nephropathy: a still unsolved puzzle. J Nephrol (2008) 0.88
Clinical evidence on hemodiafiltration: a systematic review and a meta-analysis. Semin Dial (2014) 0.88
Exploring the association between macroeconomic indicators and dialysis mortality. Clin J Am Soc Nephrol (2012) 0.88
The success story of peritoneal dialysis in Romania: analysis of differences in mortality by dialysis modality and influence of risk factors in a national cohort. Perit Dial Int (2006) 0.88
Allopurinol, uric acid, and oxidative stress in cardiorenal disease. Int Urol Nephrol (2011) 0.88
Uric acid and pentraxin-3 levels are independently associated with coronary artery disease risk in patients with stage 2 and 3 kidney disease. Am J Nephrol (2011) 0.88
Monocyte count/HDL cholesterol ratio and cardiovascular events in patients with chronic kidney disease. Int Urol Nephrol (2014) 0.87
Renal anemia of inflammation: the name is self-explanatory. Blood Purif (2011) 0.87
Prevalence and management of anaemia in renal transplant recipients: data from ten European centres. Nephron Clin Pract (2010) 0.87
Soluble TWEAK independently predicts atherosclerosis in renal transplant patients. BMC Nephrol (2013) 0.86
European best practice quo vadis? From European Best Practice Guidelines (EBPG) to European Renal Best Practice (ERBP). Nephrol Dial Transplant (2008) 0.86
Hepatitis B and C virus infection in the hemodialysis population from three romanian regions. Nephron (2015) 0.86
Prognostic significance of neutrophil gelatinase-associated lipocalin in ST-segment elevation myocardial infarction. J Investig Med (2012) 0.86
Effects of allopurinol on endothelial dysfunction: a meta-analysis. Am J Nephrol (2014) 0.86
Persistence of cardiovascular risk factors in women with previous preeclampsia: a long-term follow-up study. J Investig Med (2015) 0.86
Obstructive sleep apnea syndrome is related to the progression of chronic kidney disease. Int Urol Nephrol (2011) 0.85
Ambulatory blood pressure monitoring: from old concepts to novel insights. Int Urol Nephrol (2011) 0.85
A multicentric, international matched pair analysis of body composition in peritoneal dialysis versus haemodialysis patients. Nephrol Dial Transplant (2013) 0.84
Sudden death in hemodialysis: an update. Blood Purif (2010) 0.84
A pharmacoepidemiological study of the multi-level determinants, predictors, and clinical outcomes of biosimilar epoetin alfa for renal anaemia in haemodialysis patients: background and methodology of the MONITOR-CKD5 study. Intern Emerg Med (2011) 0.84
Efficacy of cinacalcet with low-dose vitamin D in incident haemodialysis subjects with secondary hyperparathyroidism. Nephrol Dial Transplant (2013) 0.83
Associations between serum leptin level and bone turnover in kidney transplant recipients. Clin J Am Soc Nephrol (2010) 0.83
A systematic review regarding the association of illness perception and survival among end-stage renal disease patients. Nephrol Dial Transplant (2013) 0.83
A longitudinal study on illness perceptions in hemodialysis patients: changes over time. Arch Med Sci (2013) 0.83
Hypertension and cardiovascular risk assessment in dialysis patients. Nephrol Dial Transplant (2004) 0.83
Changes in the histological spectrum of glomerular diseases in the past 16 years in the North-Eastern region of Romania. BMC Nephrol (2013) 0.83
Direct renin inhibitors: the dawn of a new era, or just a variation on a theme? Nephrol Dial Transplant (2007) 0.82
Serum gamma-glutamyltransferase levels are inversely related to endothelial function in chronic kidney disease. Int Urol Nephrol (2012) 0.82
Superior predictive value for NTproBNP compared with high sensitivity cTnT in dialysis patients: a pilot prospective observational study. Kidney Blood Press Res (2014) 0.82
Antihypertensive treatment and stroke prevention in patients with and without chronic kidney disease: a review of controlled trials. J Nephrol (2008) 0.82
Statin treatment for dyslipidemia in chronic kidney disease and renal transplantation: a review of the evidence. J Nephrol (2009) 0.81
Renal anemia: comparing current Eastern and Western European management practice (ORAMA). Ren Fail (2008) 0.81
Association of serum calcitonin with coronary artery disease in individuals with and without chronic kidney disease. Int Urol Nephrol (2011) 0.81
Cardiovascular disease in renal allograft recipients is associated with elevated sialic acid or markers of inflammation. Clin Transplant (2004) 0.81
Treatment of proliferative lupus nephritis--a critical approach. Semin Arthritis Rheum (2006) 0.81
Systematic review of the evidence underlying the association between mineral metabolism disturbances and risk of fracture and need for parathyroidectomy in CKD. Am J Kidney Dis (2009) 0.81
Changes in arterial stiffness following dialysis in relation to overhydration and to endothelial function. Int Urol Nephrol (2011) 0.81
Obstructive sleep apnea syndrome and chronic kidney disease: a new cardiorenal risk factor. Clin Exp Hypertens (2014) 0.81
Renal corpuscle morphometry with increased reliability and high level of automation. Pathol Res Pract (2006) 0.81
Tissue advanced glycation end products (AGEs), measured by skin autofluorescence, predict mortality in peritoneal dialysis. Int Urol Nephrol (2014) 0.80